FIELD: medicine, oncology. SUBSTANCE: method involves the use of eptaloprost or cycaprost. The use of clathrates of these prostaglandins is preferable. EFFECT: selective antimetastatic effect of treatment. 3 cl, 1 tbl, 5 dwg
Authors
Dates
1998-06-10—Published
1990-10-05—Filed